Advanced Neurohacking: Peptides and Technology
Dr. Daniel Stickler
Dr. Daniel L. Stickler is the Co-Founder and Chief Medical Officer of The Apeiron ZOH Corp. He is the pioneer behind systems-based precision lifestyle medicine, a new paradigm that re-defines medicine from the old symptoms-based disease model to one of limitless peak performance in all aspects of life. A physician to high-performing executives and entrepreneurs who want to upgrade their current state, he’s an author, speaker, blogger and podcaster. He is the Medical Director for the Neurohacker Collective, a Google consultant for wearable technology, epigenetics, and AI in healthcare and a guest lecturer at Stanford University on Epigenetics in Clinical Practice.
We are in a new age of advanced neurohacking where we are no longer constrained by the limitations of natural potential. The advent of neuropeptides has greatly enhanced human performance. We now have modalities of peptides, nootropics, and technology that provide a new course in cognitive evolution where we now can take the reigns of evolution into our own hands and realize super-human capabilities. We will be discussing our clinical experience in using combined therapies to create exponential results in cognitive healing, repair, and enhanced function.
The human system is adaptable. We have a familiar zone that we function in, and in order to grow, we need to get uncomfortable. This is where the body adapts and where gene expression actually changes.
Summary
- Biologics and peptides are targeted strings of amino acids that the body responds to naturally, offering high specificity with fewer off-target effects than traditional pharmaceuticals. - Neurologic peptides such as Cerebrolysin and Dihexa are used to enhance cognitive performance, accelerate learning, and support neuroprotection or recovery from brain injuries. - Specialized molecules like RG3 and Melanotan II provide longevity and anti-inflammatory benefits, with some compounds mimicking the physiological effects of exercise on the brain. - Wearable technology enables data-driven health by monitoring metrics like heart rate variability and sleep to manage the body as an "N of 1" system with limitless potential. - Continuous biometric monitoring helps identify the "familiar zone" of performance, allowing for strategic stress and recovery to trigger beneficial epigenetic adaptations.
Article
Advanced Neurohacking: Peptides And Technology
At Biohacker Summit 2019 Helsinki, Dr. Daniel Stickler Sketched A Future In Which The Brain Was Not Simply Healed, But Tuned
On 1 November 2019 in Helsinki, Finland, the Biohacker Summit 2019 Helsinki hosted a presentation that sat squarely at the intersection of medicine, ambition and self-quantification. In “Advanced Neurohacking: Peptides & Technology,” Dr. Daniel Stickler argued that the next frontier of human performance would be built from two converging forces: targeted biologics that speak the body’s native biochemical language, and wearable devices that turn physiology into a continuous stream of actionable data.
Stickler, Co-Founder and Chief Medical Officer of The Apeiron ZOH Corp, spoke not in the cautious idiom of conventional disease management, but in the lexicon of performance. His central premise was unapologetically expansive. “We look at each human being as an N of one and see the human system as a limitless potential.”
It was a line that captured both the promise and the provocation of the talk. Here was medicine reframed not as the treatment of what had gone wrong, but as the optimisation of what might still be possible.
The Rise Of Biologics As Precision Tools
For Stickler, biologics represented more than a fashionable category in health innovation. They marked a philosophical break from the blunt-force era of pharmaceuticals. Stem cells, exosomes and, above all, peptides, were presented as substances the body already recognised.
“Biologics are substances the body is familiar with,” he said. “The body responds to them instead of reacting to them, allowing us to be very specific for what we are trying to achieve.”
That distinction mattered. Traditional medications, he suggested, often carried collateral effects because they provoked the body rather than cooperating with it. Peptides, by contrast, offered specificity. They were strings of amino acids, fragments of proteins that could be sequenced, produced in laboratories and designed to target precise tissues or functions with minimal off-target disruption.
His prediction was bold, perhaps deliberately so. “Peptides are coming on so strong that they are going to overtake the pharmaceutical industry. We can take pieces of protein to rejuvenate specific tissues in the human body without any off-target effects.”
It was the language of disruption, but also of seduction: medicine not as suppression, but as surgical enhancement.
Rewiring The Brain With Neuropeptides
Much of the presentation focused on neurologic peptides, compounds that Stickler said were already being used in clinical and performance settings to improve cognition, speed recovery and potentially extend healthy lifespan.
Cerebrolysin emerged as one of the centrepieces. Derived from pig brain peptides, it was described as a potent cocktail associated with neuroprotection, memory enhancement, improved cellular growth and reduced neuroinflammation. Stickler said it had been investigated in stroke recovery, traumatic brain injury, Parkinson’s disease and Alzheimer’s disease, while also showing promise in performance contexts.
In his account, the most striking effects came when Cerebrolysin was paired with neurostimulation. In practice, he said, the combination dramatically accelerated improvements that had once taken far longer to achieve. According to Stickler, protocols involving ten sessions over five days produced gains that previously required 40 to 50 neurofeedback sessions.
The vision here was not merely one of healing damaged brains, but of making healthy brains learn faster, focus harder and recover more efficiently.
Selank, another peptide discussed at the event, occupied a different niche: anxiety. Delivered as a nasal spray, it was described as a powerful anxiolytic with additional effects on memory, focus and cerebral blood flow. Yet Stickler was careful to note variability in response. Only about 40 per cent of users, he said, were “quick responders,” while others might need a week of consistent use before the effects became clear.
Dihexa, developed at the University of Washington, was presented as one of the talk’s most evocative examples of neurohacking’s allure. Applied topically, it was said to stimulate dendritic spine growth on neurons, effectively supporting the architecture of learning itself. In practical terms, Stickler framed it as a tool for accelerated skill acquisition, useful for someone learning a language or mastering an instrument.
There was also FGL, discussed for stroke recovery and post-traumatic brain injury, and RG3, a ginsenoside derivative that Stickler included because of its neurological and longevity-related effects. RG3, he said, mimicked some of the brain benefits of exercise, activating pathways associated with mitochondrial health and resilience.
Even Melanotan II, better known in some circles for cosmetic tanning, was folded into the presentation as a molecule with anti-inflammatory and neurologic implications, particularly through its effects on melanocortin pathways.
Performance Medicine And The Cult Of Measurement
If peptides were one half of Stickler’s framework, data was the other. The talk’s second movement pivoted from molecular intervention to digital surveillance of the self.
“If you can measure it, you can manage it,” he said. “This is where we are right now in health. Everything we do, we measure it and we manage it.”
That creed defined the wearable technology section of the presentation. Stickler described a practice in which biometric monitoring was not a novelty, but a clinical instrument. Stress, sleep, activity levels, resting heart rate and glucose trends were all tracked in real time, often through consumer-facing devices such as Garmin watches, Oura rings, Biostrap and Dexcom sensors.
The implications were intensely personal. Stickler described reviewing patient data weekly, using it to assess the physiological impact of interventions and to move away from guesswork. Subjective feelings mattered, but they were no longer enough. Experience had to be matched against evidence.
Wearables, in this account, did more than count steps. They mapped the “familiar zone” of the body, the adaptive baseline from which growth required discomfort. Stress, when deliberately applied and adequately recovered from, was not an enemy. It was the trigger for epigenetic adaptation.
That idea drew performance medicine close to an older truth of training: progress requires challenge. But the biohacking twist was that challenge could now be quantified minute by minute, with algorithms translating heart rate variability into stress scores, recovery windows and even “body battery” metrics.
What The Data Revealed About Modern Life
In one of the presentation’s more striking sections, Stickler used his own biometric data to illustrate how ordinary behaviours could have outsized physiological effects. A single glass of wine, he said, reliably drove his stress markers upward. Long-distance travel proved even more punishing, with elevated stress and resting heart rate taking as long as seven days to return to baseline after a trip from Austin to Europe.
The lesson was not asceticism for its own sake. It was that the body kept score, often more faithfully than perception did.
He also highlighted emerging sleep data suggesting that the optimal duration for resting heart rate might sit closer to seven hours than the conventional eight. It was a small but telling example of the biohacker’s challenge to generic advice: averages may guide populations, but they do not necessarily optimise individuals.
Environmental monitoring, too, was entering the frame. UV exposure, pollution, pollen, heat and humidity were all cited as variables that could increasingly be tracked and folded into a larger understanding of personal resilience.
The Individual As Experiment
At the heart of Stickler’s presentation was a worldview that has become increasingly influential in wellness, longevity and elite performance circles: the human body as an experiment in continuous refinement.
“We are looking at how to increase cognitive performance and substantiate longevity through performance medicine, using neuropeptides to achieve results at an accelerated rate,” he said.
What made the talk compelling was not merely the catalogue of compounds or devices, but the coherence of the philosophy behind them. The self was treated as dynamic, measurable and modifiable. Biology was not fixed destiny. It was feedback.
Yet there was also something quietly revealing in the tension between the clinical and the aspirational. On one side stood stroke recovery, neuroinflammation and traumatic brain injury. On the other stood better focus, faster learning and longer life for already high-functioning people. Biohacking, in this formulation, borrowed legitimacy from medicine even as it leaned toward enhancement.
That tension may be precisely why such talks resonated so strongly at gatherings like Biohacker Summit 2019 Helsinki. They spoke to a culture no longer satisfied with wellness as maintenance. The new promise was optimisation, and beyond that, transcendence.
A Future Built On Peptides, Sensors And Relentless Feedback
By the end of the session, Dr. Daniel Stickler had offered more than a tour of peptides and wearables. He had articulated a model of human potential rooted in precision, feedback and intervention. It was a model in which neurochemistry could be tuned, stress could be graphed, recovery could be scheduled and longevity could be engineered through daily decisions.
Whether all of those promises would stand the test of time was, even then, an open question. But in Helsinki, on that November stage, the future was presented as something already underway: inhaled, injected, worn on the wrist and watched in real time.
For the biohacking movement, that was the deeper claim. The body was no longer merely lived in. It was monitored, edited and, perhaps, increasingly designed.
Part of Biohacker Summit 2019 Helsinki